Creo Medical Group Past Earnings Performance

Past criteria checks 0/6

Creo Medical Group's earnings have been declining at an average annual rate of -8.8%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 38.3% per year.

Key information

-8.8%

Earnings growth rate

8.3%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate38.3%
Return on equity-47.3%
Net Margin-73.9%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Creo Medical Group makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BST:1RC Revenue, expenses and earnings (GBP Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2430-22410
31 Mar 2431-22410
31 Dec 2331-22410
30 Sep 2330-23410
30 Jun 2329-25420
31 Mar 2328-26430
31 Dec 2227-27440
30 Sep 2227-28450
30 Jun 2226-28470
31 Mar 2226-26440
31 Dec 2125-25420
30 Sep 2124-23380
30 Jun 2122-21340
31 Mar 2116-21310
31 Dec 209-20280
30 Sep 205-19240
30 Jun 200-17200
31 Mar 200-17200
31 Dec 190-16190
30 Jun 190-13160
31 Mar 190-12140
31 Dec 180-10120
31 Dec 170-8100
30 Sep 170-890
30 Jun 170-880
30 Jun 161-560
29 Feb 161-340
28 Feb 150-230
28 Feb 141-230

Quality Earnings: 1RC is currently unprofitable.

Growing Profit Margin: 1RC is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 1RC is unprofitable, and losses have increased over the past 5 years at a rate of 8.8% per year.

Accelerating Growth: Unable to compare 1RC's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 1RC is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).


Return on Equity

High ROE: 1RC has a negative Return on Equity (-47.26%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies